Greenwood Capital Associates LLC Tandem Diabetes Care Inc Transaction History

Greenwood Capital Associates LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$53.22 - $123.09 $115,434 - $266,982	-2,169 Reduced 27.0%	5,863 $347,000
Q1 2022 May 10, 2022	BUY	$101.89 - $150.09 $35,050 - $51,630	344 Added 4.47%	8,032 $934,000
Q4 2021 Feb 03, 2022	BUY	$118.18 - $153.21 $4,372 - $5,668	37 Added 0.48%	7,688 $1.16 Million
Q3 2021 Oct 27, 2021	BUY	$93.51 - $129.4 $7,574 - $10,481	81 Added 1.07%	7,651 $913,000
Q2 2021 Aug 16, 2021	BUY	$77.0 - $100.19 $6,699 - $8,716	87 Added 1.16%	7,570 $737,000
Q1 2021 May 14, 2021	BUY	$81.28 - $104.34 $111,678 - $143,363	1,374 Added 22.49%	7,483 $660,000
Q4 2020 Feb 09, 2021	BUY	$86.4 - $121.75 $55,900 - $78,772	647 Added 11.85%	6,109 $585,000
Q3 2020 Nov 12, 2020	SELL	$95.43 - $116.09 $63,174 - $76,851	-662 Reduced 10.81%	5,462 $620,000
Q2 2020 Aug 12, 2020	SELL	$60.05 - $98.92 $79,806 - $131,464	-1,329 Reduced 17.83%	6,124 $606,000
Q1 2020 May 12, 2020	SELL	$47.37 - $90.04 $20,226 - $38,447	-427 Reduced 5.42%	7,453 $480,000
Q4 2019 Feb 12, 2020	BUY	$53.13 - $71.19 $124,377 - $166,655	2,341 Added 42.26%	7,880 $469,000
Q3 2019 Nov 12, 2019	BUY	$57.11 - $73.3 $316,332 - $406,008	5,539 New	5,539 $327,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.97B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwood Capital Associates LLC with notifications on news.